Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Do not violate the International Health Regulations during the COVID-19 outbreak.
Habibi, R; Burci, GL; De Campos, TC; Chirwa, D; Cinà, M; Dagron, S; Eccleston-Turner, M; Forman, L; Gostin, LO; Meier, BM; Negri, S; OOMS, G; Sekalala, S; Taylor, A; Yamin, AE; Hoffman, SJ;
2020
The Lancet, (2020).395 10225 10.1016/s0140-6736(20)30373-1.
Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients.
Boshier, FA T; Pang, J; Penner, J; Hughes, J; Parker, M; Shepherd, J; Alders, N; Bamford, A; Grandjean, L; Grunewald, S; Hatcher, J; Best, T; Dalton, C; Bynoe, PD; Frauenfelder, C; Köeglmeier, J; Myerson, P; Roy, S; Williams, R; THOMSON, EC; De Silva, TI; Goldstein, RA; Breuer, J;
2020
medRxiv preprint (2020). 10.1101/2020.11.18.20230599.
Unnecessary obstacles to COVID-19 mass testing.
PETO, J; Hunter, DJ; Riboli, E; Griffin, JL;
2020
LANCET, (2020).396 10263 10.1016/S0140-6736(20)32170-X.
Estimating under-ascertainment of COVID-19 mortality: an analysis of novel data sources to provide insight into COVID-19 dynamics in Damascus, Syria.
J. Watson, O; ALHAFFAR, M; Mehchy, Z; Whittaker, C; Akil, Z; CHECCHI, F; Ferguson, N; Ghani, A; Beals, E; Walker, P; Authors, A;
2020
(2020). 10.25561/82443.
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
LIU, Y; Morgenstern, C; Kelly, J; LOWE, R; JIT, M; CMMID COVID-19 Working Group,;
2020
medRxiv (2020). 10.1101/2020.08.11.20172643.
Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis.
SANDMANN, FG; White, PJ; Ramsay, M; JIT, M;
2020
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2020).71 12 10.1093/cid/ciaa901.
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology.
Batlle, D; Soler, MJ; Sparks, MA; Hiremath, S; South, AM; Welling, PA; Swaminathan, S; COVID-19 and ACE2 in Cardiovascular, Lung, and Kid,;
2020
Journal of the American Society of Nephrology : JASN, (2020).31 7 10.1681/asn.2020040419.
A framework for identifying and mitigating the equity harms of COVID-19 policy interventions.
GLOVER, RE; Van Schalkwyk, MC I; Akl, EA; Kristjannson, E; Lotfi, T; Petkovic, J; PETTICREW, MP; Pottie, K; Tugwell, P; Welch, V;
2020
Journal of Clinical Epidemiology, (2020).128, 10.1016/j.jclinepi.2020.06.004.
An integrated <i>in silico</i> immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.
WARD, D; Higgins, M; PHELAN, JE; HIBBERD, ML; CAMPINO, S; CLARK, TG;
2020
(2020). 10.1101/2020.05.11.089409.
The right to health in times of pandemic: what can we learn from the UK's response to the COVID-19 outbreak?.
MONTEL, L;
2020
(2020).